{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:26:53Z","timestamp":1789590413255,"version":"build-2803163510"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:00Z","timestamp":1491436800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s11926-017-0654-8","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T06:41:34Z","timestamp":1491460894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Ankylosing Spondylitis: HLA-B*27-Positive Versus HLA-B*27-Negative Disease"],"prefix":"10.1007","volume":"19","author":[{"given":"Nurullah","family":"Akko\u00e7","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Yarkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6k\u00e7e","family":"Kenar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"key":"654_CR1","first-page":"117","volume-title":"Ankylosing spondylitis and the spondyloarthropathies","author":"N Akkoc","year":"2006","unstructured":"Akkoc N, Khan MA. Epidemiology of ankylosing spondylitis and related spondyloarthropathies. In: Weisman MH, Reveille JD, van der Heijde D, editors. Ankylosing spondylitis and the spondyloarthropathies. St. Louis: Mosby; 2006. p. 117\u201331."},{"issue":"12","key":"654_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006634","volume":"4","author":"NN Haroon","year":"2014","unstructured":"Haroon NN, Paterson JM, Li P, Haroon N. Increasing proportion of female patients with ankylosing spondylitis: a population-based study of trends in the incidence and prevalence of AS. BMJ Open. 2014;4(12):e006634. doi:\n10.1136\/bmjopen-2014-006634\n\n.","journal-title":"BMJ Open"},{"issue":"5393","key":"654_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/242121a0","volume":"242","author":"MF Caffrey","year":"1973","unstructured":"Caffrey MF, James DC. Human lymphocyte antigen association in ankylosing spondylitis. Nature. 1973;242(5393):121.","journal-title":"Nature"},{"issue":"14","key":"654_CR4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1056\/NEJM197304052881403","volume":"288","author":"L Schlosstein","year":"1973","unstructured":"Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973;288(14):704\u20136. doi:\n10.1056\/NEJM197304052881403\n\n.","journal-title":"N Engl J Med"},{"issue":"7809","key":"654_CR5","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","volume":"1","author":"DA Brewerton","year":"1973","unstructured":"Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet. 1973;1(7809):904\u20137.","journal-title":"Lancet"},{"issue":"4","key":"654_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00002281-200307000-00001","volume":"15","author":"DA Brewerton","year":"2003","unstructured":"Brewerton DA. Discovery: HLA and disease. Curr Opin Rheumatol. 2003;15(4):369\u201373.","journal-title":"Curr Opin Rheumatol"},{"key":"654_CR7","doi-asserted-by":"publisher","unstructured":"Khan MA. An update on the genetic polymorphism of HLA-B27 (HLA-B*27), comprising 204 alleles and 155 subtypes (and still counting). Curr Rheumatol Rep. 2017;In Press.","DOI":"10.1007\/s11926-017-0640-1"},{"key":"654_CR8","unstructured":"\u2022\u2022 Khan MA. Ankylosing spondylitis\u2014axial Spondyloarthritis West Islip. New York: PCI (Professional Communications, Inc); 2016. Excellent handbook providing comprehensive yet concise up-to- date information on all aspects of axial spondyloarthritis, with particular emphasis on current treatment options including the latest biologic therapies."},{"key":"654_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","volume":"33","author":"P Bowness","year":"2015","unstructured":"\u2022\u2022 Bowness P. HLA-B27. Annu Rev Immunol. 2015;33:29\u201348. doi:\n10.1146\/annurev-immunol-032414-112110\n\n. A thorough and comprehensive review discussing the function of HLA-B27, its disease associations, and its pathogenic role in AS.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"654_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ng.3528","volume":"48","author":"D Ellinghaus","year":"2016","unstructured":"\u2022\u2022 Ellinghaus D, Jostins L, Spain SL, Cortes A, Bethune J, Han B, et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet. 2016;48(5):510\u20138. doi:\n10.1038\/ng.3528\n\n. This global study investigating the pleiotropy and the relationship between five common, inflammatory diseases that commonly occur together in families and in individuals showed that these conditions similar genetic backgrounds.","journal-title":"Nat Genet"},{"issue":"Database issue","key":"654_CR11","doi-asserted-by":"publisher","first-page":"D423","DOI":"10.1093\/nar\/gku1161","volume":"43","author":"J Robinson","year":"2015","unstructured":"Robinson J, Halliwell JA, Hayhurst JD, Flicek P, Parham P, Marsh SG. The IPD and IMGT\/HLA database: allele variant databases. Nucleic Acids Res. 2015;43(Database issue):D423\u201331. doi:\n10.1093\/nar\/gku1161\n\n.","journal-title":"Nucleic Acids Res"},{"issue":"9570","key":"654_CR12","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/s0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369(9570):1379\u201390. doi:\n10.1016\/s0140-6736(07)60635-7\n\n.","journal-title":"Lancet"},{"issue":"4","key":"654_CR13","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.20990","volume":"52","author":"M Rudwaleit","year":"2005","unstructured":"Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum. 2005;52(4):1000\u20138. doi:\n10.1002\/art.20990\n\n.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"654_CR14","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaikh B, Turner SP, Chao CC, Sathe M, Grein J, et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells. Nat Med. 2012;18(7):1069\u201376. doi:\n10.1038\/nm.2817\n\n.","journal-title":"Nat Med"},{"issue":"8","key":"654_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105684","volume":"9","author":"P Lin","year":"2014","unstructured":"Lin P, Bach M, Asquith M, Lee AY, Akileswaran L, Stauffer P, et al. HLA-B27 and human beta2-microglobulin affect the gut microbiota of transgenic rats. PLoS One. 2014;9(8):e105684. doi:\n10.1371\/journal.pone.0105684\n\n.","journal-title":"PLoS One"},{"issue":"3","key":"654_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.autrev.2006.11.003","volume":"6","author":"MA Khan","year":"2007","unstructured":"Khan MA, Mathieu A, Sorrentino R, Akkoc N. The pathogenetic role of HLA-B27 and its subtypes. Autoimmun Rev. 2007;6(3):183\u20139. doi:\n10.1016\/j.autrev.2006.11.003\n\n.","journal-title":"Autoimmun Rev"},{"key":"654_CR17","doi-asserted-by":"publisher","unstructured":"\u2022 Brown MA, Kenna T, Wordsworth BP. Genetics of ankylosing spondylitis - insights into pathogenesis. Nat Rev Rheumatol. 2015;advance online publication. doi:\n10.1038\/nrrheum.2015.133\n\n. This paper provides a comprehensive review of the recent progress in AS genetics and describes how the recently discovered genetic associations has expanded our understanding of its pathogenesis and led to the development of novel therapeutic strategies.","DOI":"10.1038\/nrrheum.2015.133"},{"issue":"8","key":"654_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/ng.873","volume":"43","author":"DM Evans","year":"2011","unstructured":"Evans DM, Spencer CCA, Pointon JJ, Su Z, Harvey D, Kochan G, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011;43(8):761\u20137. \nhttp:\/\/www.nature.com\/ng\/journal\/v43\/n8\/abs\/ng.873.html\n\n - supplementary-information","journal-title":"Nat Genet"},{"issue":"4","key":"654_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/annrheumdis-2011-200347","volume":"71","author":"N Haroon","year":"2012","unstructured":"Haroon N, Tsui FW, Uchanska-Ziegler B, Ziegler A, Inman RD. Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis. Ann Rheum Dis. 2012;71(4):589\u201395. doi:\n10.1136\/annrheumdis-2011-200347\n\n.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"654_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ng.2667","volume":"45","author":"A Cortes","year":"2013","unstructured":"International Genetics of Ankylosing Spondylitis C, Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2013;45(7):730\u20138. doi:\n10.1038\/ng.2667\n\n.","journal-title":"Nat Genet"},{"issue":"1","key":"654_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.coi.2012.11.002","volume":"25","author":"S Keidel","year":"2013","unstructured":"Keidel S, Chen L, Pointon J, Wordsworth P. ERAP1 and ankylosing spondylitis. Curr Opin Immunol. 2013;25(1):97\u2013102.","journal-title":"Curr Opin Immunol"},{"issue":"49","key":"654_CR22","doi-asserted-by":"publisher","first-page":"17594","DOI":"10.1073\/pnas.1408882111","volume":"111","author":"E Reeves","year":"2014","unstructured":"Reeves E, Colebatch-Bourn A, Elliott T, Edwards CJ, James E. Functionally distinct ERAP1 allotype combinations distinguish individuals with ankylosing spondylitis. Proc Natl Acad Sci. 2014;111(49):17594\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"654_CR23","first-page":"539","volume":"9","author":"MA Khan","year":"2014","unstructured":"Khan MA, Magrey M. Gene\u2013gene interactions of HLA-B27 and ERAP1 in ankylosing spondylitis: finding the pieces of the puzzle. Int J Clin. 2014;9(6):539\u201342.","journal-title":"Int J Clin"},{"issue":"4","key":"654_CR24","first-page":"391","volume":"2","author":"AH Hersh","year":"1950","unstructured":"Hersh AH, Stecher RM, Solomon WM, Wolpaw R, Hauser H. Heredity in ankylosing spondylitis; a study of fifty families. Am J Hum Genet. 1950;2(4):391\u2013408.","journal-title":"Am J Hum Genet"},{"issue":"4 Suppl 2","key":"654_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/rheumatology\/XXII.suppl_2.18","volume":"22","author":"S Linden van der","year":"1983","unstructured":"van der Linden S, Valkenburg H, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a family and population study. Br J Rheumatol. 1983;22(4 Suppl 2):18\u20139.","journal-title":"Br J Rheumatol"},{"issue":"10","key":"654_CR26","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/1529-0131(199710)40:10&lt;1823::AID-ART15&gt;3.0.CO;2\u20131","volume":"40","author":"MA Brown","year":"1997","unstructured":"Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997;40(10):1823\u20138. doi:\n10.1002\/1529-0131(199710)40:10&lt;1823::AID-ART15&gt;3.0.CO;2\u20131\n\n.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"654_CR27","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/ard.59.11.883","volume":"59","author":"MA Brown","year":"2000","unstructured":"Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000;59(11):883\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"654_CR28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1136\/ard.37.6.504","volume":"37","author":"JC Woodrow","year":"1978","unstructured":"Woodrow JC, Eastmond CJ. HLA B27 and the genetics of ankylosing spondylitis. Ann Rheum Dis. 1978;37(6):504\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"654_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00005792-197809000-00005","volume":"57","author":"MC Hochberg","year":"1978","unstructured":"Hochberg MC, Bias WB, Arnett Jr FC. Family studies in HLA-B27 associated arthritis. Medicine (Baltimore). 1978;57(5):463\u201375.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"654_CR30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/tan.12186","volume":"82","author":"M Yang","year":"2013","unstructured":"\u2022 Yang M, Xu M, Pan X, Hu Z, Li Q, Wei Y, et al. Epidemiological comparison of clinical manifestations according to HLA-B*27 carrier status of Chinese ankylosing spondylitis patients. Tissue Antigens. 2013;82(5):338\u201343. doi:\n10.1111\/tan.12186\n\n. This nationwide epidemiological study from China investigated and reported on the clinical diversity between HLA-B27+ and HLA-B27\u2212 AS patients.","journal-title":"Tissue Antigens"},{"issue":"11","key":"654_CR31","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1136\/ard.2011.152975","volume":"70","author":"HY Chung","year":"2011","unstructured":"Chung HY, Machado P, van der Heijde D, D\u2019Agostino MA, Dougados M. HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis. Ann Rheum Dis. 2011;70(11):1930\u20136. doi:\n10.1136\/ard.2011.152975\n\n.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"654_CR32","first-page":"560","volume":"28","author":"PD Sampaio-Barros","year":"2001","unstructured":"Sampaio-Barros PD, Bertolo MB, Kraemer MH, Neto JF, Samara AM. Primary ankylosing spondylitis: patterns of disease in a Brazilian population of 147 patients. J Rheumatol. 2001;28(3):560\u20135.","journal-title":"J Rheumatol"},{"issue":"3","key":"654_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10165-009-0153-5","volume":"19","author":"MA Nazarinia","year":"2009","unstructured":"Nazarinia MA, Ghaffarpasand F, Heiran HR, Habibagahi Z. Pattern of ankylosing spondylitis in an Iranian population of 98 patients. Mod Rheumatol. 2009;19(3):309\u201315. doi:\n10.1007\/s10165-009-0153-5\n\n.","journal-title":"Mod Rheumatol"},{"issue":"12","key":"654_CR34","first-page":"2583","volume":"29","author":"M Paardt","year":"2002","unstructured":"Paardt M, Dijkmans B, Giltay E, van der Horst-Bruinsma I. Dutch patients with familial and sporadic ankylosing spondylitis do not differ in disease phenotype. J Rheumatol. 2002;29(12):2583\u20134.","journal-title":"J Rheumatol"},{"issue":"6","key":"654_CR35","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3346\/jkms.2014.29.6.782","volume":"29","author":"HW Kim","year":"2014","unstructured":"Kim HW, Choe HR, Lee SB, Chang WI, Chae HJ, Moon JY, et al. Phenotype difference between familial and sporadic ankylosing spondylitis in Korean patients. J Korean Med Sci. 2014;29(6):782\u20137. doi:\n10.3346\/jkms.2014.29.6.782\n\n.","journal-title":"J Korean Med Sci"},{"key":"654_CR36","first-page":"S717","volume":"54","author":"K de Vlam","year":"2006","unstructured":"de Vlam K, Vastesaeger N, Brasseur J, Boonen A, Lenaerts J, Lesaffre E, et al. Belgian patients with familial and sporadic ankylosing spondylitis differ in disease phenotype. Arthritis Rheum. 2006;54:S717\u20138.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"654_CR37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/art.1780360515","volume":"36","author":"A Calin","year":"1993","unstructured":"Calin A, Kennedy LG, Edmunds L, Will R. Familial versus sporadic ankylosing spondylitis. Two different diseases? Arthritis Rheum. 1993;36(5):676\u201381.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"654_CR38","first-page":"822","volume":"29","author":"R Almodovar","year":"2011","unstructured":"Almodovar R, Font P, Zarco-Montejo P, Collantes E, Mulero J, Gratacos J, et al. Phenotypic differences between familial versus sporadic ankylosing spondylitis: a cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER). Clin Exp Rheumatol. 2011;29(5):822\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"654_CR39","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/rheumatology\/keh577","volume":"44","author":"CT Chou","year":"2005","unstructured":"Chou CT, Lin KC, Wei JC, Tsai WC, Ho HH, Hwang CM, et al. Study of undifferentiated spondyloarthropathy among first-degree relatives of ankylosing spondylitis probands. Rheumatology (Oxford). 2005;44(5):662\u20135. doi:\n10.1093\/rheumatology\/keh577\n\n.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"654_CR40","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/acr.21601","volume":"64","author":"R Joshi","year":"2012","unstructured":"Joshi R, Reveille JD, Brown MA, Weisman MH, Ward MM, Gensler LS, et al. Is there a higher genetic load of susceptibility loci in familial ankylosing spondylitis? Arthritis Care Res (Hoboken). 2012;64(5):780\u20134. doi:\n10.1002\/acr.21601\n\n.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"654_CR41","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1399-0039.1978.tb01280.x","volume":"11","author":"MA Khan","year":"1978","unstructured":"Khan MA, Kushner I, Braun WE, Zachary AA, Steinberg AG. HLA--B27 homozygosity in ankylosing spondylitis: relationship to risk and severity. Tissue Antigens. 1978;11(5):434\u20138.","journal-title":"Tissue Antigens"},{"issue":"6","key":"654_CR42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/ard.2005.041103","volume":"65","author":"E Jaakkola","year":"2006","unstructured":"Jaakkola E, Herzberg I, Laiho K, Barnardo MC, Pointon JJ, Kauppi M, et al. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis. 2006;65(6):775\u201380. doi:\n10.1136\/ard.2005.041103\n\n.","journal-title":"Ann Rheum Dis"},{"key":"654_CR43","unstructured":"Kim TJ, Na KS, Lee HJ, Lee B, Kim TH. HLA-B27 homozygosity has no influence on clinical manifestations and functional disability in ankylosing spondylitis. Clin Exp Rheumatol. 2009;27(4):574\u20139."},{"issue":"2","key":"654_CR44","first-page":"302","volume":"14","author":"ME Suarez-Almazor","year":"1987","unstructured":"Suarez-Almazor ME, Russell AS. B27 homozygosity and ankylosing spondylitis. J Rheumatol. 1987;14(2):302\u20134.","journal-title":"J Rheumatol"},{"issue":"3","key":"654_CR45","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/art.1780200306","volume":"20","author":"FC Arnett Jr","year":"1977","unstructured":"Arnett Jr FC, Schacter BZ, Hochberg MC, Hsu SH, Bias WB. Homozygosity for HLA-B27. Impact on rheumatic disease expression in two families. Arthritis Rheum. 1977;20(3):797\u2013804.","journal-title":"Arthritis Rheum"},{"key":"654_CR46","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Kim T-J, Sung I-H, Lee S, Joo KB, Choi JH, Park D-J, et al. HLA-B27 homozygosity has no influence on radiographic damage in ankylosing spondylitis: Observation Study of Korean spondyloArthropathy Registry (OSKAR) data. Joint Bone Spine. 2013;80(5):488\u201391. doi:\n10.1016\/j.jbspin.2012.12.003\n\n. This study, with the largest number of HLA-B*27 homozygous cases with AS, found no role for HLA-B*27 homozygosity on the structural progression in this disease.","DOI":"10.1016\/j.jbspin.2012.12.003"},{"key":"654_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/03009749009097070","volume":"87","author":"A Linssen","year":"1990","unstructured":"Linssen A. B27+ disease versus B27- disease. Scand J Rheumatol Suppl. 1990;87:111\u20138. discussion 8\u20139","journal-title":"Scand J Rheumatol Suppl"},{"issue":"3","key":"654_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jbspin.2009.11.015","volume":"77","author":"TJ Kim","year":"2010","unstructured":"Kim TJ, Kim TH. Clinical spectrum of ankylosing spondylitis in Korea. Joint Bone Spine. 2010;77(3):235\u201340. doi:\n10.1016\/j.jbspin.2009.11.015\n\n.","journal-title":"Joint Bone Spine"},{"issue":"12","key":"654_CR49","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s11926-013-0374-7","volume":"15","author":"I Olivieri","year":"2013","unstructured":"Olivieri I, D\u2019Angelo S, Padula A, Leccese P, Palazzi C. Spondyloarthritis with onset after age 45. Curr Rheumatol Rep. 2013;15(12):374. doi:\n10.1007\/s11926-013-0374-7\n\n.","journal-title":"Curr Rheumatol Rep"},{"key":"654_CR50","first-page":"54","volume":"3","author":"JM Van der Linden","year":"1977","unstructured":"Van der Linden JM, De Ceulaer K, Van Romunde LK, Cats A. Ankylosing spondylitis without HLA B27. J Rheumatol Suppl. 1977;3:54\u20136.","journal-title":"J Rheumatol Suppl"},{"issue":"4","key":"654_CR51","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/art.1780200401","volume":"20","author":"MA Khan","year":"1977","unstructured":"Khan MA, Kushner I, Braun WE. Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum. 1977;20(4):909\u201312.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"654_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","volume":"23","author":"E Feldtkeller","year":"2003","unstructured":"Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 2003;23(2):61\u20136. doi:\n10.1007\/s00296-002-0237-4\n\n.","journal-title":"Rheumatol Int"},{"issue":"3","key":"654_CR53","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/art.24483","volume":"60","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Haibel H, Baraliakos X, Listing J, Marker-Hermann E, Zeidler H, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum. 2009;60(3):717\u201327. doi:\n10.1002\/art.24483\n\n.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"654_CR54","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jbspin.2011.01.013","volume":"78","author":"M Dougados","year":"2011","unstructured":"Dougados M, d\u2019Agostino MA, Benessiano J, Berenbaum F, Breban M, Claudepierre P, et al. The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint, bone, spine : revue du rhumatisme. 2011;78(6):598\u2013603. doi:\n10.1016\/j.jbspin.2011.01.013\n\n.","journal-title":"Joint, bone, spine : revue du rhumatisme"},{"issue":"5","key":"654_CR55","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3346\/jkms.2002.17.5.669","volume":"17","author":"JH Lee","year":"2002","unstructured":"Lee JH, Jun JB, Jung S, Bae SC, Yoo DH, Kim TY, et al. Higher prevalence of peripheral arthritis among ankylosing spondylitis patients. J Korean Med Sci. 2002;17(5):669\u201373.","journal-title":"J Korean Med Sci"},{"issue":"10","key":"654_CR56","first-page":"1883","volume":"21","author":"B Amor","year":"1994","unstructured":"Amor B, Santos RS, Nahal R, Listrat V, Dougados M. Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol. 1994;21(10):1883\u20137.","journal-title":"J Rheumatol"},{"issue":"1","key":"654_CR57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","volume":"74","author":"C Stolwijk","year":"2015","unstructured":"Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(1):65\u201373. doi:\n10.1136\/annrheumdis-2013-203582\n\n.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"654_CR58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/09273948.2010.542269","volume":"19","author":"D Wakefield","year":"2011","unstructured":"Wakefield D, Chang JH, Amjadi S, Maconochie Z, Abu El-Asrar A, McCluskey P. What is new HLA-B27 acute anterior uveitis? Ocul Immunol Inflamm. 2011;19(2):139\u201344. doi:\n10.3109\/09273948.2010.542269\n\n.","journal-title":"Ocul Immunol Inflamm"},{"key":"654_CR59","doi-asserted-by":"publisher","unstructured":"Nahir M, Scharf Y, Brik R, Scharf Y, Gidoni O, Barzilai A. The influence of HL-A B27 on the clinical picture of ankylosing spondylitis. Rheumatol Rehabil. 1979;18(1):10\u20132.","DOI":"10.1093\/rheumatology\/18.1.10"},{"issue":"2","key":"654_CR60","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/rheumatology\/kev296","volume":"55","author":"R Queiro","year":"2016","unstructured":"Queiro R, Morante I, Cabezas I, Acasuso B. HLA-B27 and psoriatic disease: a modern view of an old relationship. Rheumatology (Oxford). 2016;55(2):221\u20139. doi:\n10.1093\/rheumatology\/kev296\n\n.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"654_CR61","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1053\/sarh.2002.33470","volume":"31","author":"R Queiro","year":"2002","unstructured":"Queiro R, Sarasqueta C, Belzunegui J, Gonzalez C, Figueroa M, Torre-Alonso JC. Psoriatic spondyloarthropathy: a comparative study between HLA-B27 positive and HLA-B27 negative disease. Semin Arthritis Rheum. 2002;31(6):413\u20138.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"654_CR62","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/ard.42.2.142","volume":"42","author":"RD Armstrong","year":"1983","unstructured":"Armstrong RD, Panayi GS, Welsh KI. Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis. Ann Rheum Dis. 1983;42(2):142\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"654_CR63","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1136\/annrheumdis-2012-202922","volume":"72","author":"P Machado","year":"2013","unstructured":"Machado P, Landewe R, Braun J, Baraliakos X, Hermann KG, Hsu B, et al. Ankylosing spondylitis patients with and without psoriasis do not differ in disease phenotype. Ann Rheum Dis. 2013;72(6):1104\u20137. doi:\n10.1136\/annrheumdis-2012-202922\n\n.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"654_CR64","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/rheumatology\/keq129","volume":"49","author":"J Braun","year":"2010","unstructured":"Braun J, Rudwaleit M, Kary S, Kron M, Wong RL, Kupper H. Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasis. Rheumatology (Oxford). 2010;49(8):1578\u201389. doi:\n10.1093\/rheumatology\/keq129\n\n.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"654_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099533","volume":"9","author":"SP Sinikumpu","year":"2014","unstructured":"Sinikumpu SP, Huilaja L, Jokelainen J, Koiranen M, Auvinen J, Hagg PM, et al. High prevalence of skin diseases and need for treatment in a middle-aged population. A Northern Finland Birth Cohort 1966 study. PLoS One. 2014;9(6):e99533. doi:\n10.1371\/journal.pone.0099533\n\n.","journal-title":"PLoS One"},{"issue":"3","key":"654_CR66","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.berh.2006.03.010","volume":"20","author":"M Rudwaleit","year":"2006","unstructured":"Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol. 2006;20(3):451\u201371. doi:\n10.1016\/j.berh.2006.03.010\n\n.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"654_CR67","first-page":"173","volume":"24","author":"PV Voulgari","year":"2011","unstructured":"Voulgari PV. Rheumatological manifestations in inflammatory bowel disease. Ann Gastroenterol. 2011;24(3):173\u201380.","journal-title":"Ann Gastroenterol"},{"issue":"5","key":"654_CR68","first-page":"499","volume":"7","author":"H Mielants","year":"1989","unstructured":"Mielants H, Veys EM, Cuvelier C, De Vos M. Subclinical involvement of the gut in undifferentiated spondylarthropathies. Clin Exp Rheumatol. 1989;7(5):499\u2013504.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"654_CR69","first-page":"511","volume":"29","author":"O Palm","year":"2002","unstructured":"Palm O, Moum B, Ongre A, Gran JT. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol. 2002;29(3):511\u20135.","journal-title":"J Rheumatol"},{"issue":"6","key":"654_CR70","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A","volume":"44","author":"J Hamersma","year":"2001","unstructured":"Hamersma J, Cardon LR, Bradbury L, Brophy S, van der Horst-Bruinsma I, Calin A, et al. Is disease severity in ankylosing spondylitis genetically determined? Arthritis Rheum. 2001;44(6):1396\u2013400. doi:\n10.1002\/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A\n\n.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"654_CR71","first-page":"1775","volume":"31","author":"S Brophy","year":"2004","unstructured":"Brophy S, Hickey S, Menon A, Taylor G, Bradbury L, Hamersma J, et al. Concordance of disease severity among family members with ankylosing spondylitis? J Rheumatol. 2004;31(9):1775\u20138.","journal-title":"J Rheumatol"},{"issue":"3","key":"654_CR72","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/1529-0131(199803)41:3<460::AID-ART12>3.0.CO;2-X","volume":"41","author":"MA Brown","year":"1998","unstructured":"Brown MA, Kennedy LG, Darke C, Gibson K, Pile KD, Shatford JL, et al. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum. 1998;41(3):460\u20135. doi:\n10.1002\/1529-0131(199803)41:3<460::AID-ART12>3.0.CO;2-X\n\n.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"654_CR73","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1136\/annrheumdis-2013-204835","volume":"74","author":"A Cortes","year":"2015","unstructured":"Cortes A, Maksymowych WP, Wordsworth BP, Inman RD, Danoy P, Rahman P, et al. Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis. Ann Rheum Dis. 2015;74(7):1387\u201393. doi:\n10.1136\/annrheumdis-2013-204835\n\n.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"654_CR74","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3899\/jrheum.080831","volume":"36","author":"A Boonen","year":"2009","unstructured":"Boonen A, vander Cruyssen B, de Vlam K, Steinfeld S, Ribbens C, Lenaerts J, et al. Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome. J Rheumatol. 2009;36(6):1249\u201355. doi:\n10.3899\/jrheum.080831\n\n.","journal-title":"J Rheumatol"},{"key":"654_CR75","doi-asserted-by":"publisher","unstructured":"Ward MM, Hendrey MR, Malley JD, Learch TJ, Davis Jr JC, Reveille JD, et al. Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. Arthritis Rheum. 2009;61(7):859\u201366. doi:\n10.1002\/art.24585\n\n.","DOI":"10.1002\/art.24585"},{"issue":"11","key":"654_CR76","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3899\/jrheum.100094","volume":"37","author":"P Atagunduz","year":"2010","unstructured":"Atagunduz P, Aydin SZ, Bahadir C, Erer B, Direskeneli H. Determinants of early radiographic progression in ankylosing spondylitis. J Rheumatol. 2010;37(11):2356\u201361. doi:\n10.3899\/jrheum.100094\n\n.","journal-title":"J Rheumatol"},{"key":"654_CR77","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Ramiro S, Stolwijk C, van Tubergen A, van der Heijde D, Dougados M, van den Bosch F, et al. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis. 2013; doi:\n10.1136\/annrheumdis-2013-204055\n\n. This long term prospective data from the European Outcome in Ankylosing Spondylitis International Study (OASIS) radiographic progression in AS is highly variable in the individual patient, more severe in HLA-B*27-positive male patients and those with a higher existing level of spinal damage present at baseline.","DOI":"10.1136\/annrheumdis-2013-204055"},{"issue":"5","key":"654_CR78","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/art.33465","volume":"64","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, Haibel H, Listing J, Marker-Hermann E, Zeidler H, Braun J, et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondyloarthritis. Arthritis Rheum. 2012;64(5):1388\u201398. doi:\n10.1002\/art.33465\n\n.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"654_CR79","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/ard.2010.145995","volume":"70","author":"D Poddubnyy","year":"2011","unstructured":"Poddubnyy D, Rudwaleit M, Haibel H, Listing J, Marker-Hermann E, Zeidler H, et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis. 2011;70(8):1369\u201374. doi:\n10.1136\/ard.2010.145995\n\n.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"654_CR80","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1002\/art.24024","volume":"58","author":"AN Bennett","year":"2008","unstructured":"Bennett AN, McGonagle D, O\u2019Connor P, Hensor EM, Sivera F, Coates LC, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum. 2008;58(11):3413\u20138. doi:\n10.1002\/art.24024\n\n.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"654_CR81","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1002\/art.21913","volume":"54","author":"D Heijde van der","year":"2006","unstructured":"van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2006;54(7):2136\u201346. doi:\n10.1002\/art.21913\n\n.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"654_CR82","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/ard.2003.016386","volume":"63","author":"M Rudwaleit","year":"2004","unstructured":"Rudwaleit M, Listing J, Brandt J, Braun J, Sieper J. Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis. 2004;63(6):665\u201370. doi:\n10.1136\/ard.2003.016386\n\n.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"654_CR83","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/ard.2010.147744","volume":"70","author":"N Vastesaeger","year":"2011","unstructured":"Vastesaeger N, van der Heijde D, Inman RD, Wang Y, Deodhar A, Hsu B, et al. Predicting the outcome of ankylosing spondylitis therapy. Ann Rheum Dis. 2011;70(6):973\u201381. doi:\n10.1136\/ard.2010.147744\n\n.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"654_CR84","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3899\/jrheum.141278","volume":"42","author":"X Baraliakos","year":"2015","unstructured":"Baraliakos X, Koenig AS, Jones H, Szumski A, Collier D, Bananis E. Predictors of clinical remission under anti-tumor necrosis factor treatment in patients with ankylosing spondylitis: pooled analysis from large randomized clinical trials. J Rheumatol. 2015;42(8):1418\u201326.","journal-title":"J Rheumatol"},{"issue":"4","key":"654_CR85","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3899\/jrheum.081048","volume":"36","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Claudepierre P, Wordsworth P, Cortina EL, Sieper J, Kron M, et al. Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis. J Rheumatol. 2009;36(4):801\u20138. doi:\n10.3899\/jrheum.081048\n\n.","journal-title":"J Rheumatol"},{"issue":"Suppl 10","key":"654_CR86","first-page":"533","volume":"63","author":"KM Fagerli","year":"2011","unstructured":"Fagerli KM, Lie E, Heiberg MS, van der Heijde D, Kalstad S, Knut M, et al. Predictors of ASDAS major improvement in patients with ankylosing spondylitis (AS) receiving their first TNF inhibitor: results from a longitudinal observational study. Arthritis Rheum. 2011;63(Suppl 10):533.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"654_CR87","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2014-000017","volume":"1","author":"JR Maneiro","year":"2015","unstructured":"Maneiro JR, Souto A, Salgado E, Mera A, Gomez-Reino JJ. Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis. RMD Open. 2015;1(1):e000017. doi:\n10.1136\/rmdopen-2014-000017\n\n.","journal-title":"RMD Open"},{"issue":"7","key":"654_CR88","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/art.23606","volume":"58","author":"H Haibel","year":"2008","unstructured":"Haibel H, Rudwaleit M, Listing J, Heldmann F, Wong RL, Kupper H, et al. Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. Arthritis Rheum. 2008;58(7):1981\u201391. doi:\n10.1002\/art.23606\n\n.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"654_CR89","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/annrheumdis-2012-201766","volume":"72","author":"J Sieper","year":"2013","unstructured":"Sieper J, van der Heijde D, Dougados M, Mease PJ, Maksymowych WP, Brown MA, et al. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1). Ann Rheum Dis. 2013;72(6):815\u201322. doi:\n10.1136\/annrheumdis-2012-201766\n\n.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"654_CR90","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/art.38721","volume":"66","author":"M Dougados","year":"2014","unstructured":"Dougados M, van der Heijde D, Sieper J, Braun J, Maksymowych WP, Citera G, et al. Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2014;66(8):2091\u2013102. doi:\n10.1002\/art.38721\n\n.","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"654_CR91","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1002\/art.39257","volume":"67","author":"J Sieper","year":"2015","unstructured":"Sieper J, van der Heijde D, Dougados M, Maksymowych WP, Scott BB, Boice JA, et al. A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2015;67(10):2702\u201312. doi:\n10.1002\/art.39257\n\n.","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"654_CR92","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/art.22812","volume":"56","author":"B Thjodleifsson","year":"2007","unstructured":"Thjodleifsson B, Geirsson AJ, Bjornsson S, Bjarnason I. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Arthritis Rheum. 2007;56(8):2633\u20139. doi:\n10.1002\/art.22812\n\n.","journal-title":"Arthritis Rheum"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-017-0654-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-017-0654-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-017-0654-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T05:59:04Z","timestamp":1494309544000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-017-0654-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,6]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["654"],"URL":"https:\/\/doi.org\/10.1007\/s11926-017-0654-8","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,6]]},"article-number":"26"}}